Chronic sinusitis is a common affliction that affects an estimated 14.6 percent of Americans. The condition is marked by inflammation of the sinuses that blocks the nasal passages, causing chronic infections. Symptoms include nasal congestion, sinus pain and pressure, loss of smell and taste, nasal discharge, headache, fatigue and depression.
Medications may provide temporary relief, but their effectiveness over the long term is not very impressive, prompting many patients to turn to surgery that involves enlarging the sinus cavities responsible for drainage. While sinus surgery is effective at relieving symptoms, a large number of patients contend with recurrent sinus infections within a year. At that point they may opt for follow-up surgery, and the process often repeats itself.
How Does Propel Work?
The Propel steroid-releasing implant is an alternative treatment for patients experiencing chronic sinus infections. It is the first (and only) product on the market that targets the inflamed sinus tissues directly, opening them up for improved drainage and a reduction in symptoms.
Approved by the FDA in 2013, Propel is safe and effective and carries fewer risks of post-surgical scarring or inflammation. Patients typically have a smaller chance of requiring follow-up surgery.1
The implant, inserted during an endoscopic sinus procedure, resembles a spring, and delivers a measured dose of mometasone furoate, an anti-inflammatory steroid that gradually dissolves. It is completely absorbed by the body four to six weeks after implantation, with lasting results.
If you are bothered by chronic sinusitis and are looking for a long-term solution, schedule an appointment with Dr. Stolovitzky to learn if Propel is a viable option for you.
Call Dr. Stolovitzky at (404) 921-5474 for more information or to schedule an appointment.
 Bioabsorbable steroid-releasing implants in the frontal sinus ostia: a pooled analysis. Singh A, Luong AU, Fong KJ, Ow RA, Han JK, Gerencer R, Stolovitzky JP, Stambaugh JW, Raman A. Int Forum Allergy Rhinol. 2019 Feb;9(2):131-139